147 related articles for article (PubMed ID: 15327403)
61. Different effects of mibefradil and amlodipine on coronary vessels and during beta-adrenergic stimulation in conscious dogs.
Heloire F; Hittinger L; Champagne S; Suto Y; Houel R; Ennezat PV; Sambin L; Crozatier B; Su JB
J Cardiovasc Pharmacol; 2002 Dec; 40(6):898-906. PubMed ID: 12451323
[TBL] [Abstract][Full Text] [Related]
62. Effects of amlodipine and lacidipine on cardiac remodelling and renin production in salt-loaded stroke-prone hypertensive rats.
Kyselovic J; Krenek P; Wibo M; Godfraind T
Br J Pharmacol; 2001 Dec; 134(7):1516-22. PubMed ID: 11724758
[TBL] [Abstract][Full Text] [Related]
63. Effects of alacepril and amlodipine on the renal injury induced by a high-cholesterol diet in rats.
Atarashi K; Takagi M; Minami M; Ishiyama A
J Hypertens; 1999 Dec; 17(12 Pt 2):1983-6. PubMed ID: 10703899
[TBL] [Abstract][Full Text] [Related]
64. Effect of amlodipine on renin secretion and renin gene expression in rats.
Schricker K; Hamann M; Macher A; Krämer BK; Kaissling B; Kurtz A
Br J Pharmacol; 1996 Oct; 119(4):744-50. PubMed ID: 8904650
[TBL] [Abstract][Full Text] [Related]
65. Angiotensin converting enzyme inhibition and calcium channel blockade in incipient diabetic nephropathy. The Melbourne Diabetic Nephropathy Study Group.
Jerums G; Allen TJ; Tsalamandris C; Cooper ME
Kidney Int; 1992 Apr; 41(4):904-11. PubMed ID: 1513112
[TBL] [Abstract][Full Text] [Related]
66. Cardiovascular risk, renal hypertensive damage, and effects of amlodipine treatment in transgenic TGR(mREN2)27 rats.
Witte K; Schnecko A; Schmidt T; Voll C; Kränzlin B; Lemmer B
Gen Pharmacol; 1999 Nov; 33(5):423-30. PubMed ID: 10553884
[TBL] [Abstract][Full Text] [Related]
67. The calcium channel blocker nitrendipine attenuates renal and glomerular hypertrophy in diabetic rats.
Nielsen B; Gronbaek H; Osterby R; Orskov H; Flyvbjerg A
Exp Nephrol; 1999; 7(3):242-50. PubMed ID: 10352365
[TBL] [Abstract][Full Text] [Related]
68. Amlodipine at high dose increases preproendothelin-1 expression in the ventricles and aorta of normotensive rats.
Krenek P; Morel N; Kyselovic J; Wibo M
J Hypertens; 2004 Apr; 22(4):827-35. PubMed ID: 15126926
[TBL] [Abstract][Full Text] [Related]
69. Amlodipine prevents and reverses the elevation in [Ca2+]i and the impaired phagocytosis of PMNL of diabetic rats.
Seyrek N; Marcinkowski W; Smogorzewski M; Demerdash TM; Massry SG
Nephrol Dial Transplant; 1997 Feb; 12(2):265-72. PubMed ID: 9132643
[TBL] [Abstract][Full Text] [Related]
70. CaV3.2 T-type calcium channels in peripheral sensory neurons are important for mibefradil-induced reversal of hyperalgesia and allodynia in rats with painful diabetic neuropathy.
Obradovic ALj; Hwang SM; Scarpa J; Hong SJ; Todorovic SM; Jevtovic-Todorovic V
PLoS One; 2014; 9(4):e91467. PubMed ID: 24705276
[TBL] [Abstract][Full Text] [Related]
71. Impaired mechanisms of leukocyte adhesion in vitro by the calcium channel antagonist mibefradil.
Lijnen PJ
Cardiovasc Drugs Ther; 2002 May; 16(3):179-80. PubMed ID: 12374893
[No Abstract] [Full Text] [Related]
72. Combined aliskiren and amlodipine reduce albuminuria via reduction in renal inflammation in diabetic rats.
Matavelli LC; Huang J; Siragy HM
J Cardiovasc Pharmacol; 2012 Mar; 59(3):281-7. PubMed ID: 22075749
[TBL] [Abstract][Full Text] [Related]
73. Antioxidant effect of T-type calcium channel blockers in gastric injury.
Bilici D; Banoğlu ZN; Kiziltunç A; Avci B; Ciftçioğlu A; Bilici S
Dig Dis Sci; 2002 Apr; 47(4):850-5. PubMed ID: 11991620
[TBL] [Abstract][Full Text] [Related]
74. Calcium channel blocker enhances beneficial effects of an angiotensin II AT1 receptor blocker against cerebrovascular-renal injury in type 2 diabetic mice.
Rafiq K; Sherajee SJ; Hitomi H; Nakano D; Kobori H; Ohmori K; Mori H; Kobara H; Masaki T; Kohno M; Nishiyama A
PLoS One; 2013; 8(12):e82082. PubMed ID: 24339994
[TBL] [Abstract][Full Text] [Related]
75. Urinary mRNA levels of ELR-negative CXC chemokine ligand and extracellular matrix in diabetic nephropathy.
Wang G; Lai FM; Chow KM; Kwan BC; Pang WF; Luk CC; Leung CB; Li PK; Szeto CC
Diabetes Metab Res Rev; 2015 Oct; 31(7):699-706. PubMed ID: 25865428
[TBL] [Abstract][Full Text] [Related]
76. C-peptide ameliorates renal injury in type 2 diabetic rats through protein kinase A-mediated inhibition of fibronectin synthesis.
Xu S; Jiang Y; Wang H; Wang Z; Liu H; Peng L; Fang Q; Deng T; You J; Zhou X; Zhang W; Lou J
Biochem Biophys Res Commun; 2015 Mar; 458(3):674-680. PubMed ID: 25684188
[TBL] [Abstract][Full Text] [Related]
77. Renoprotective effects of a selective estrogen receptor modulator, raloxifene, in an animal model of diabetic nephropathy.
Dixon A; Wells CC; Singh S; Babayan R; Maric C
Am J Nephrol; 2007; 27(2):120-8. PubMed ID: 17308373
[TBL] [Abstract][Full Text] [Related]
78. Effects of low-dose and early versus late perindopril treatment on the progression of severe diabetic nephropathy in (mREN-2)27 rats.
Mifsud SA; Skinner SL; Cooper ME; Kelly DJ; Wilkinson-Berka JL
J Am Soc Nephrol; 2002 Mar; 13(3):684-692. PubMed ID: 11856772
[TBL] [Abstract][Full Text] [Related]
79. Podocyte number in normotensive type 1 diabetic patients with albuminuria.
White KE; Bilous RW; Marshall SM; El Nahas M; Remuzzi G; Piras G; De Cosmo S; Viberti G
Diabetes; 2002 Oct; 51(10):3083-9. PubMed ID: 12351451
[TBL] [Abstract][Full Text] [Related]
80. Effect of bis-1,4-dihydropyridine in the kidney of diabetic rats.
Gómez-Pliego R; Gómez-Zamudio J; Velasco-Bejarano B; Ibarra-Barajas M; Villalobos-Molina R
J Pharmacol Sci; 2013; 122(3):184-92. PubMed ID: 23823933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
